Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epilepsy With Partial-onset Seizures”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00563459
What this trial is testing

Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

Who this might be right for
EpilepsySeizures
SK Life Science, Inc. 89
Testing effectiveness (Phase 2)Study completedNCT01002820
What this trial is testing

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Who this might be right for
Epilepsy, Complex Partial
Marinus Pharmaceuticals 11
Post-approval studies (Phase 4)Active Not RecruitingNCT06453213
What this trial is testing

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

Who this might be right for
Focal Onset Seizure
SK Life Science, Inc. 49
Large-scale testing (Phase 3)Study completedNCT01336621
What this trial is testing

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS)

Who this might be right for
Epilepsy
GlaxoSmithKline 98
Large-scale testing (Phase 3)Looking for participantsNCT07594158
What this trial is testing

Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds

Who this might be right for
Partial Epilepsy
Ono Pharmaceutical Co., Ltd. 20
Large-scale testing (Phase 3)Study completedNCT01506882
What this trial is testing

An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy

Who this might be right for
EpilepsyPartial Onset Seizures
UCB Japan Co. Ltd. 71
Large-scale testing (Phase 3)Study completedNCT00210782
What this trial is testing

A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment

Who this might be right for
Epilepsy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 262
Large-scale testing (Phase 3)Ended earlyNCT00448539
What this trial is testing

Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Who this might be right for
Refractory Partial Onset Seizures
Eisai Inc. 286
Large-scale testing (Phase 3)Study completedNCT00152373
What this trial is testing

Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS

Who this might be right for
Epilepsy, Partial
UCB Pharma 192
Large-scale testing (Phase 3)Study completedNCT00160628
What this trial is testing

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

Who this might be right for
Epilepsy, Partial
UCB Pharma 100
Early research (Phase 1)Study completedNCT04903314
What this trial is testing

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 26
Not applicableStudy completedNCT01532726
What this trial is testing

Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)

Who this might be right for
Epilepsy
Bial - Portela C S.A. 56
Large-scale testing (Phase 3)Study completedNCT00490035
What this trial is testing

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma SA 399
Not applicableActive Not RecruitingNCT03417297
What this trial is testing

A Pilot Study: Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy

Who this might be right for
Partial Seizures With Secondary GeneralizationFocal Epilepsy With Secondary Generalization
University of North Carolina, Chapel Hill 10
Testing effectiveness (Phase 2)Study completedNCT00105040
What this trial is testing

A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
UCB Pharma 87
Post-approval studies (Phase 4)Study completedNCT00713622
What this trial is testing

Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate

Who this might be right for
Epilepsy
Eisai Limited 2
Post-approval studies (Phase 4)Study completedNCT00955357
What this trial is testing

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Who this might be right for
Partial Epilepsies
UCB Pharma 461
Testing effectiveness (Phase 2)Study completedNCT04244175
What this trial is testing

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 154
Not applicableStudy completedNCT02687711
What this trial is testing

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures

Who this might be right for
Epilepsy With POS With or Without Secondary Generalization
UCB Biopharma S.P.R.L. 544
Large-scale testing (Phase 3)WithdrawnNCT00175864
What this trial is testing

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma
Next Page